BioCryst Pharmaceuticals
BCRX
#4475
Rank
S$2.90 B
Marketcap
S$11.59
Share price
-3.84%
Change (1 day)
16.86%
Change (1 year)

Earnings for BioCryst Pharmaceuticals (BCRX)

Earnings in 2025 (TTM): S$0.34 Billion

According to BioCryst Pharmaceuticals 's latest financial reports the company's current earnings are S$0.87 Billion. , an increase over its 2024 earnings that were of -S$0.12 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for BioCryst Pharmaceuticals from 1994 to 2025

Annual earnings

Year Earnings Change
2025 S$0.34 B-407.51%
2024 -S$0.12 Billion-61.56%
2023 -S$0.3 Billion-7.43%
2022 -S$0.32 Billion34.42%
2021 -S$0.24 Billion-0.55%
2020 -S$0.24 Billion67.88%
2019 -S$0.14 Billion7.55%
2018 -S$0.14 Billion53.92%
2017 -S$84.56 Million19.29%
2016 -S$70.89 Million28.19%
2015 -S$55.3 Million-4.8%
2014 -S$58.09 Million50.09%
2013 -S$38.7 Million-23.29%
2012 -S$50.46 Million-26.19%
2011 -S$68.36 Million54.78%
2010 -S$44.17 Million150.1%
2009 -S$17.66 Million-49.43%
2008 -S$34.92 Million14.07%
2007 -S$30.61 Million-49.31%
2006 -S$60.39 Million72.87%
2005 -S$34.94 Million22.08%
2004 -S$28.62 Million75.3%
2003 -S$16.33 Million-25.36%
2002 -S$21.88 Million225.05%
2001 -S$6.73 Million-56.6%
2000 -S$15.51 Million50.63%
1999 -S$10.3 Million38.05%
1998 -S$7.46 Million-52.46%
1997 -S$15.69 Million58.44%
1996 -S$9.9 Million-14.44%
1995 -S$11.57 Million28.57%
1994 -S$9 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Gilead Sciences
GILD
S$12.59 B 3,563.92%๐Ÿ‡บ๐Ÿ‡ธ USA
GSK plc
GSK
S$12.71 B 3,600.86%๐Ÿ‡ฌ๐Ÿ‡ง UK
Sarepta Therapeutics
SRPT
-S$0.33 Billion-194.31%๐Ÿ‡บ๐Ÿ‡ธ USA
Repligen
RGEN
S$0.10 B-68.62%๐Ÿ‡บ๐Ÿ‡ธ USA
Novavax
NVAX
S$0.48 B 40.24%๐Ÿ‡บ๐Ÿ‡ธ USA
Celldex Therapeutics
CLDX
-S$0.37 Billion-207.47%๐Ÿ‡บ๐Ÿ‡ธ USA
NanoViricides
NNVC
-S$10.45 Million-103.04%๐Ÿ‡บ๐Ÿ‡ธ USA
Cel-Sci
CVM
-S$31.83 Million-109.26%๐Ÿ‡บ๐Ÿ‡ธ USA
Emergent BioSolutions
EBS
S$0.21 B-38.18%๐Ÿ‡บ๐Ÿ‡ธ USA